- Joined
- Sep 30, 2004
- Messages
- 33,982
- Likes
- 49,496
Yes, and they have Wegovy, which is what made me the big bucks.Isn’t Novo Nordisk the leader in treating diabetes? If they have a huge block buster drug for obesity that might cannibalize their diabetes side.
The snack food companies certainly got slammed by the weight loss drugs’ emergence.
Lilly has now gotten approval for Zepbound (AKA Wegovy) to be marketed for weight loss. It is more than just a GLP1 agonist, with a second biochemical property that will likely supplant Wegovy as the industry darling. I've heard projections for it to possibly become the most widely used drug on the planet.